Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (154)

« Back to Publications

Prevalence and risk factors of vitamin D deficiency among Afghan primary school children.

Rahimi BA. et al, (2024), Sci Rep, 14

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.

Fadilah I. et al, (2024), PLoS Med, 21

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling WHK. et al, (2024), PLoS Med, 21

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria.

Mukaka M. et al, (2023), EBioMedicine, 96

Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening.

Kosasih A. et al, (2023), Pathogens, 12

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.

Taylor WRJ. et al, (2023), PLoS Negl Trop Dis, 17

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.

Taylor WR. et al, (2023), Lancet Infect Dis, 23, 471 - 483

Treatment outcomes and risk factors of death in childhood tuberculous meningitis in Kandahar, Afghanistan: a prospective observational cohort study.

Rahimi BA. et al, (2022), Trans R Soc Trop Med Hyg, 116, 1181 - 1190

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria.

Taylor WRJ. et al, (2022), N Engl J Med, 387

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria.

Watson JA. and White NJ., (2022), N Engl J Med, 387, 282 - 283

A comparative study of the proximity to nomadic travel routes and environmental factors on the occurrence of cutaneous leishmaniasis in Kohgiluyeh and Boyer-Ahmad province, southwestern Iran.

Ghatee MA. et al, (2022), Transbound Emerg Dis, 69, e547 - e553

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data.

WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group ., (2022), BMC Med, 20

Concomitant intramyocardial and hepatic hydatid cysts diagnosed by multi-modality imaging: A rare case report.

Nguyen HTT. et al, (2022), Front Cardiovasc Med, 9

A family cluster of cutaneous Leishmania major infection unresponsive to intralesional meglumine antimonial: Case reports.

Ziaee M. et al, (2022), Indian J Med Microbiol, 40, 451 - 454

Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.

Rahimi BA. et al, (2022), PLoS One, 17

Load More

1
2
3
4
5
6
7
...
»